Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0,21%
1 091,51
-2,30
-0,21%
—1 093,811 096,521 100,221 091,51——
SIXC
Communications
SIXC
Communications
SIXC
+0,22%
610,11
+1,34
+0,22%
—608,77608,77612,97608,77——
SIXE
Energy
SIXE
Energy
SIXE
-1,34%
1 237,98
-16,83
-1,34%
—1 254,811 253,011 253,871 226,33——
SIXI
Industrials
SIXI
Industrials
SIXI
-0,93%
1 744,71
-16,40
-0,93%
—1 761,111 764,271 766,881 744,71——
SIXM
Financials
SIXM
Financials
SIXM
-0,37%
640,18
-2,40
-0,37%
—642,58644,87648,48640,18——
SIXR
Staples
SIXR
Staples
SIXR
-0,18%
849,58
-1,55
-0,18%
—851,13855,66858,75845,56——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0,23%
217,48
-0,50
-0,23%
—217,98217,98218,65216,88——
SIXT
Technology
SIXT
Technology
SIXT
+1,52%
3 260,69
+48,86
+1,52%
—3 211,833 227,213 268,383 226,55——
SIXU
Utilities
SIXU
Utilities
SIXU
-0,69%
942,45
-6,53
-0,69%
—948,98948,58957,83941,97——
SIXV
Health care
SIXV
Health care
SIXV
-0,52%
1 466,80
-7,72
-0,52%
—1 474,521 479,031 481,041 466,80——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0,22%
2 397,50
+5,38
+0,22%
—2 392,122 396,952 421,222 382,32——
1IOVA:BIT
Iovance Biotherapeutics Inc
€2,80
-1,41%
(-0,040) 1D
30 Apr., 17:26:00 GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 1IOVA...
Open
€2,80
High
€2,80
Low
€2,80
Mkt. cap
1,52 mjd
Avg. vol.
369,00
Volume
1,00
52-wk high
€18,79
52-wk low
€1,10
No. of employees
975
News stories
From sources across the web
Profile
Iovance Biotherapeutics, Inc. is a biopharmaceutical startup based in San Carlos, California. The company works to develop tumor-infiltrating lymphocyte therapies against cancer. Wikipedia
About Iovance Biotherapeutics Inc
CEO-
Employees975
Founded2007
HeadquartersSan Carlos, Kalifornië, Verenigde State van Amerika
Sector-
Websiteiovance.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mrt. 2025
Jun. 2025
Sep. 2025
Des. 2025
Revenue
49,32 m
59,95 m
67,46 m
86,77 m
Cost of goods sold
49,74 m
56,66 m
38,48 m
43,11 m
Cost of revenue
49,74 m
56,66 m
38,48 m
43,11 m
Research and development expenses
76,88 m
79,36 m
75,17 m
71,20 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
43,92 m
37,70 m
34,56 m
36,40 m
Operating expense
120,80 m
117,06 m
118,74 m
117,12 m
Total operating expenses
170,54 m
173,73 m
157,21 m
160,23 m
Operating income
-121,22 m
-113,77 m
-89,76 m
-73,46 m
Other non operating income
-
-
-
-2,71 m
EBT including unusual items
-118,00 m
-109,67 m
-93,66 m
-71,72 m
EBT excluding unusual items
-120,15 m
-109,67 m
-88,52 m
-73,06 m
Income tax expense
-1,84 m
1,99 m
-2,40 m
184,00 k
Effective tax rate
1,56%
-1,81%
2,57%
-0,26%
Other operating expenses
-
-
-
-
Net income
-116,16 m
-111,66 m
-91,25 m
-71,90 m
Net profit margin
-235,51%
-186,25%
-135,28%
-82,87%
Earnings per share
-0,36
-0,33
-0,25
-0,18
Interest and investment income
1,07 m
4,10 m
1,24 m
3,10 m
Interest expense
-
-
-
-
Net interest expenses
1,07 m
4,10 m
1,24 m
3,10 m
Depreciation and amortization charges
-
-
9,01 m
9,52 m
EBITDA
-113,03 m
-104,71 m
-81,00 m
-63,53 m
Gain or loss from assets sale
44,00 k
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer